Veterinary Chemistry Analyzer Market Size, COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI3806
Veterinary Chemistry Analyzer Market size is expected to gain considerable momentum from 2021 to 2027. This is attributable to the escalating usage of this medical device for the diagnosis of diseases in pets, including inflammation, anemia, viral infection, and other phenomena. In addition, its increasing adoption as an alternative to microscopic examination due to its ability to improve work efficiency and deliver accurate and reliable results will also augment the industry demand. Chemistry analyzers refer to laboratory devices used to determine the concentration of proteins, electrolytes, metabolites, and drugs in the samples of plasma, serum, cerebrospinal fluid, urine, and other body fluids. Veterinary blood chemistry analyzers employ biological and chemical technology to conduct immunoassay, electrolyte, and chemical tests on these clinical samples to detect diseases and assay some therapeutic drugs.
Rise in pet acceptance and the growing burden of foot and mouth disease are the prominent trends expediting the veterinary chemistry analyzer market growth during the forecast timeline. According to the World Organization for Animal Health’s statistics, FMD is estimated to circulate in over 77% of the global livestock population in the Middle East, Africa, and Asia. Moreover, the rising incidences of zoonotic diseases among humans and animals will also boost the market expansion, given the significant role played by veterinary clinical analyzers in the diagnosis and treatment of multiple diseases.
Glucose monitoring is set to emerge as a key application segment in the veterinary chemistry analyzer market by 2027, as a result of the increasing prevalence of diabetes mellitus in pets. Likewise, the availability of in-house veterinary hematology analyzers, along with the increase in home monitoring of blood glucose for efficient veterinary diabetes management will further drive the product demand for glucose monitoring applications.
The Europe veterinary chemistry analyzer market will witness a major upsurge by 2027, on account of the considerable increase in pet population in the region. According to WZF GmbH’s report, 47% of households adopted a pet in Germany in 2020, a surge of around one million animals over 2019. Additionally, the escalating number of veterinary practitioners, alongside the rapid spread of pathogens like pestiviruses among cattle and other animals in countries like the UK and Italy, will contribute to the regional outlook.
The competitive landscape of the global veterinary chemistry analyzer market comprises companies such as Randox Laboratories, IDEXX Laboratories, Heska, Eurolyser Diagnostica, Diconex, DiaSys Diagnostic Systems, Arkray, Diagnostic Technologies, Alfa Wassermann, and Abaxis (Zoetis), among others. These companies are focusing on strategies like new product launches, acquisitions, and mergers to capture an appreciable market share and gain a competitive edge over rivals in the global market. For instance, in March 2021, Carolina Liquid Chemistries entered a partnership deal with Seamaty. This deal was inked with an aim to market and produce SMT-120V, a state-of-the-art veterinary automated biochemistry analyzer, to cater to the veterinary market, especially mobile veterinary labs.
COVID-19 to Impact Veterinary Chemistry Analyzer Market Trends:
Veterinary hospitals showcased a significant drop in pet care compliance during the initial months of the novel coronavirus pandemic. In order to limit the virus transmission and conserve PPE, public health agencies limited veterinary services to urgent care and sick pets, as well as encouraged them to forego elective procedures. This disruption in the delivery of animal wellness care services, coupled with the decline in the number of clients due to health concerns, may hamper the industry dynamics.
However, an unprecedented increase in the adoption of companion animals to reduce psychological stress induced by the coronavirus crisis may aid industry recovery in the upcoming years. According to a Deutsche Welle report, German residents adopted another million house pets during the pandemic, bringing the total to nearly 35 million. Additionally, the prevalence of animal-to-human diseases and the mounting demand for animal protein could further stimulate the need for veterinary clinical chemistry analyzers.
The veterinary chemistry analyzer market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2027 for the following segments:
Market, By Product
- Blood Gas & Electrolyte Analyzers
- Chemistry Analyzers
- Urine Analyzers
- Preloaded Single-slide Reagent Panels
- Preloaded Multiple Reagent Panels
- Test Strips
Market, By Application
- Blood Gas & Electrolyte Analysis
- Blood Chemistry Analysis
- Glucose Monitoring
Market, By Animal Type
- Companion Animals
- Other Companion Animals
- Sheep & Goats
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability